SPL 0.00% 10.5¢ starpharma holdings limited

ADR volume etc, page-3

  1. 4,861 Posts.
    lightbulb Created with Sketch. 256
    AJ that is explained in the announcement approval is probably only a couple of months of the phase three trials are a formality and will be finished soon this is a short term treatment and solution not like doing phase 3 oncologysecond qtr 2017 should all be done and dusted and we have the product in production already, it;s all good interesting though what Antibotter is saying about Phizer they may make a move to buy who knows?
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.